<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02182648</url>
  </required_header>
  <id_info>
    <org_study_id>etomidate children 20140625</org_study_id>
    <nct_id>NCT02182648</nct_id>
  </id_info>
  <brief_title>Bispectral Index Guiding Etomidate Used in Children Aged 3 to 10 for Clinical Anesthesia Induction</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Henan Provincial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Henan Provincial Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research through using bispectral index to guide the induced dose and speed of etomidate
      lipid emulsion for pediatric total venous anesthesia,and to provide a reference for clinical
      anesthesia physician.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>October 2014</start_date>
  <primary_completion_date type="Anticipated">May 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the amount of drugs</measure>
    <time_frame>from the beginning of induction to Bispectral Index &lt; 50,up to 5 minutes</time_frame>
    <description>the amount of etomidate,propofol and sevoflurane used in anesthesia induction</description>
  </primary_outcome>
  <primary_outcome>
    <measure>the drugs used time</measure>
    <time_frame>from the beginning of induction to Bispectral Index &lt; 50,expected to be within 1 minute</time_frame>
    <description>the injection time of etomidate and propofol, and the inhale time of sevoflurane during anesthesia induction</description>
  </primary_outcome>
  <primary_outcome>
    <measure>numbers of muscular fibrillation</measure>
    <time_frame>from the beginning of induction to Bispectral Index &lt; 50,up to 5 minutes</time_frame>
    <description>numbers of muscular fibrillation in anesthesia induction</description>
  </primary_outcome>
  <primary_outcome>
    <measure>degree of inflammation reaction</measure>
    <time_frame>baseline,5 minutes after indution,5 minutes before operation end,30 mimutes、24h and 48h after operation</time_frame>
    <description>serum levels of interleukin 6 and tumor necrosis factor α will be measured at each time point using ELISA method</description>
  </primary_outcome>
  <primary_outcome>
    <measure>adrenal function</measure>
    <time_frame>baseline,5 minutes after indution,5 minutes before operation end,30 mimutes、24h and 48h after operation</time_frame>
    <description>serum level of cortisol will be measured at each time point using radioimmunoassay</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>hemodynamic parameters</measure>
    <time_frame>from the beginning of induction to skin closure, up to 3 hours</time_frame>
    <description>heart rate,blood pressure,electrocardiogram and pulse oxygen saturation recorded at 4 time points including before anesthesia induction,before endotracheal intubation,after endotracheal intubation and after operation immediately</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sedation degree</measure>
    <time_frame>from the beginning of induction to skin closure, up to 3 hours</time_frame>
    <description>Bispectral index,train-of-four stimulation and the temperature recorded at 4 time points including before anesthesia induction,before endotracheal intubation,after endotracheal intubation and after operation immediately</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Bispectral Index</condition>
  <condition>Pediatric</condition>
  <condition>Etomidate</condition>
  <condition>Induction</condition>
  <arm_group>
    <arm_group_label>etomidate group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>infusion of etomidate at 2 minutes before anesthesia induction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>propofol group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>infusion of propofol at 2 minutes before anesthesia induction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sevoflurane group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>inhale sevoflurane for anesthesia induction and maintenance</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>etomidate</intervention_name>
    <description>intravenous injection midazolam 0.08 mg/kg, fentanyl 0.002 mg/kg, cisatracurium 0.15 mg/kg for induction of anesthesia.
infusion of etomidate at 2 minutes before anesthesia induction</description>
    <arm_group_label>etomidate group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>propofol</intervention_name>
    <description>intravenous injection midazolam 0.08 mg/kg, fentanyl 0.002 mg/kg, cisatracurium 0.15 mg/kg for induction of anesthesia.
infusion of propofol at 2 minutes before anesthesia induction</description>
    <arm_group_label>propofol group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sevoflurane</intervention_name>
    <description>intravenous injection midazolam 0.08 mg/kg, fentanyl 0.002 mg/kg, cisatracurium 0.15 mg/kg for induction of anesthesia.
inhale sevoflurane for anesthesia induction and maintenance</description>
    <arm_group_label>sevoflurane group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. obtain informed consent;

          2. undergoing elective hypospadias repair surgery under general anesthesia;

          3. American society of anesthesiologists (ASA) class I-II;

          4. aged between 3-10 years old;

          5. BMI is 18.5-30 kg/m2;

        Exclusion Criteria:

          1. systolic blood pressure≥180 mmHg or&lt;90 mmHg, diastolic blood pressure≥110 mmHg or&lt;60
             mmHg;

          2. serious heart, brain, liver, kidney, lung, endocrine diseases or serious infections;

          3. long-term use of hormone or a history of adrenal cortex inhibition;

          4. suspected or confirmed difficult airway;

          5. suspected or confirmed abuse of narcotic analgesic drugs, psychotropic drugs;

          6. neuromuscular disease;

          7. mental instability, or have a mental illness;

          8. allergic to investigational products or with other contraindication

          9. participated in other study within 30 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Enqiang Chang</last_name>
    <email>clinicaltriallh@163.com</email>
  </overall_contact>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 29, 2014</study_first_submitted>
  <study_first_submitted_qc>July 2, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 8, 2014</study_first_posted>
  <last_update_submitted>July 2, 2014</last_update_submitted>
  <last_update_submitted_qc>July 2, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 8, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
    <mesh_term>Etomidate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

